Click Here to
Subscribe
Breaking
News, Updates,
& More
Stay Up
to Date

Hematologic Cancers

Tiffany Richards expresses her positive outlook on daratumumab, citing that the treatment has helped extend life expentancies.
Tiffany Richards provides an overview of the most common questions she hears from patients regarding daratumumab.
Tiffany Richards discusses the numerous, often unmet, needs of patients with multiple myeloma.
Tiffany Richards shares anecdotes that illustrate why it's important to really know your patients in order to effectively care for them.
Tiffany Richards stresses the importance of educating patients about side effects and what to do when these side effects begin to present.
Tiffany Richards is excited about all the new multiple myeloma treatments that are being introduced, but understands that the question of how to best utilize these drugs still remains to be answered.
Tiffany Richards insists on the importance of survivorship care in patients with multiple myeloma and explains how to make sure patients stay as healthy as possible for as long as possible.
The US Food and Drug Administration has approved nivolumab (Opdivo) for patients with classical Hodgkin Lymphoma that has progressed or relapsed following autologous hematopoietic stem cell transplantation and post-transplant brentuximab vedotin, according to an announcement by the agency. Notably, the intravenous drug was granted accelerated approval, and Breakthrough Therapy Designation.
Atheer Kaddis, SVP Sales/Business Development of Diplomat Specialty Pharmacy, describes in his opinion how specialty pharmacy can assist patients with polycythemia vera
Listen as Atheer Kaddis discusses the additional services that pharmacies can prescribe to patients with polycythemia vera and their families.
Page 3 of 5
Results 21 - 30 of 47